Onychodystrophy following the use of leflunomide for seronegative rheumatoid arthritis

Dermatol Ther. 2020 Nov;33(6):e14491. doi: 10.1111/dth.14491. Epub 2020 Nov 12.

Authors

Aaminah F Azhar¹, Bradley Evanson^{1

2}, Palak K Parekh^{1

2}

Affiliations

¹ Texas A&M University College of Medicine, Bryan, Texas, USA.
² Department of Dermatology, Baylor Scott & White, Temple, Texas, USA.

PMID: 33135835
DOI: 10.1111/dth.14491

No abstract available

Publication types

Letter

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Antirheumatic Agents* / adverse effects
Arthritis, Rheumatoid* / diagnosis
Arthritis, Rheumatoid* / drug therapy
Humans
Leflunomide / adverse effects

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Leflunomide